Bray B M, Jones H M, Grundy E M
Department of Anaesthesia, Middlesex Hospital, London.
Anaesthesia. 1987 Nov;42(11):1188-90. doi: 10.1111/j.1365-2044.1987.tb05226.x.
Atropine 600 micrograms was given either intravenously or intratracheally and the change in heart rate noted in a double-blind, randomised study of 40 anaesthetised patients. There was no significant difference between the two groups in the maximum increase in heart rate, 20.3 beats/minute in the tracheal compared to 21.4 beats/minute in the intravenous group. However, the maximum increase occurred significantly earlier in the tracheal group, 45.5 seconds after administration compared to 95.5 seconds in the intravenous group (p less than 0.01, 95% confidence interval 36.8-63.2 seconds). This study supports the clinical observation that tracheal and intravenous atropine are equally effective and suggests that the trachea should be the route of choice when a rapid response is required.
在一项针对40名麻醉患者的双盲随机研究中,静脉注射或气管内给予600微克阿托品,并记录心率变化。两组心率最大增幅无显著差异,气管内给药组为20.3次/分钟,静脉给药组为21.4次/分钟。然而,气管内给药组心率最大增幅出现的时间明显更早,给药后45.5秒出现,而静脉给药组为95.5秒(p<0.01,95%置信区间为36.8 - 63.2秒)。本研究支持气管内和静脉注射阿托品同样有效的临床观察结果,并表明在需要快速反应时,气管内给药应作为首选途径。